Impact of chronic obstructive pulmonary disease on mortality: A large national cohort study

Author:

Park Hye Yun1ORCID,Kang Danbee23,Lee Hyun4ORCID,Shin Sun Hye1,Kang Minwoong2,Kong Sunga3,Rhee Chin Kook5ORCID,Cho Juhee236ORCID,Yoo Kwang Ha7

Affiliation:

1. Division of Pulmonary and Critical Care Medicine, Department of MedicineSamsung Medical Center, Sungkyunkwan University School of Medicine Seoul Republic of Korea

2. Center for Clinical EpidemiologySamsung Medical Center Seoul Republic of Korea

3. Department of Clinical Research Design and Evaluation, SAIHSTSungkyunkwan University Seoul Republic of Korea

4. Division of Pulmonary Medicine and Allergy, Department of Internal MedicineHanyang University College of Medicine Seoul Republic of Korea

5. Division of Pulmonary, Allergy and Critical Care Medicine, Department of Internal MedicineSeoul St Mary's Hospital, College of Medicine, The Catholic University of Korea Seoul Republic of Korea

6. Department of EpidemiologyJohns Hopkins University Bloomberg School of Public Health Baltimore MD USA

7. Department of Internal MedicineKonkuk University School of Medicine Seoul Republic of Korea

Funder

National Research Foundation of Korea

Publisher

Wiley

Subject

Pulmonary and Respiratory Medicine

Reference33 articles.

1. Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015

2. World Health Organization. Projections of mortality and causes of death 2015 and 2030. [Accessed 5 June 2018.] Available from URL:http://www.who.int/healthinfo/global_burden_disease/projections/en/

3. Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global Strategy for the Diagnosis Management and Prevention of COPD.2019. [Accessed 1 Apr 2019.] Available from URL:http://www.goldcopd.org/

4. Ascertainment of cause-specific mortality in COPD: operations of the TORCH Clinical Endpoint Committee

5. Cause-specific mortality adjudication in the UPLIFT® COPD trial: Findings and recommendations

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3